AYA Share Price Performance
AU$0
-0.88 (-100.00%)
Price AU$0
Share Pricen/a
Artrya Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 18 Fair Values set on narratives written by author
AYA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Artrya Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.10
- -57,103.57%
- -58,592.86%
- 0%
About AYA
- Founded
- 2018
- Employees
- n/a
- CEO
- WebsiteView website
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.
